Navigation Links
Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
Date:8/7/2008

RALEIGH, N.C., Aug. 7 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Nader Naeymi-Rad has been appointed Chief Operating Officer. His former role at Campbell Alliance of Senior Vice President and head of the firm's Brand Management Practice will be assumed by Darius Naigamwalla under the same title.

This new senior executive management role for Mr. Naeymi-Rad follows an 11-year tenure at Campbell Alliance extending from the original founding of the firm in 1997 by CEO John Campbell. In fact, Mr. Naeymi-Rad was the first employee that Mr. Campbell hired upon founding the firm.

"My relationship with Nader dates back more than 14 years to when we first worked together at Glaxo [now GlaxoSmithKline]. I have depended on him as my friend and trusted business advisor since that time. I'm proud to appoint him to this new senior executive management role in which he can continue to build upon his long-standing track record of success here at Campbell Alliance," stated Mr. Campbell.

Since joining Campbell Alliance, Mr. Naeymi-Rad has played a pivotal role in the growth of the firm and, specifically, the Brand Management Practice. He has worked on more than 500 client projects with pharmaceutical and biotech companies in a dozen countries across North America, the United Kingdom, Europe, and Asia. He has led the development of the Brand Management Practice from its inception to its present state. The practice currently has more than 80 consulting professionals around the world, and under Mr. Naeymi-Rad's leadership, it has maintained at least 35% year-over-year revenue growth since its inception. Mr. Naeymi-Rad also led the development of new service offerings including the Brand Management Practice's Launch Playbook(TM) (launch planning and execution) and Innovation2Value(TM) (commercial planning) capabilities. In addition, he helped launch and co-lead the firm's Business Development Practice and spearheaded the development of the firm's operations in the United Kingdom and Europe.

In his new role as Chief Operating Officer, Mr. Naeymi-Rad will oversee all business operations of the six consulting practice areas at Campbell Alliance and work to refine core business processes and improve operational alignment among the practice areas. These efforts will include enhancing methods and tools, identifying and shaping new service offerings and new potential practice areas, and leading the firm's next generation approach to account management.

"I'm proud to say that our business has demonstrated a consistently aggressive growth pace while maintaining stellar client satisfaction. I'm looking forward to the challenge of taking on this new role and helping the firm to further differentiate its offerings and continue its expansion into both new practice areas and geographic areas," stated Mr. Naeymi-Rad.

Mr. Naeymi-Rad has been published in numerous industry journals and is a frequent speaker at industry conferences, having served in a chairperson role on many occasions, covering topics related to developing and implementing commercial strategies and improving commercial processes.

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com .

CONTACT:

James Forte

Director, Public and Media Relations

Campbell Alliance

+1 919 844 7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
3. John Marshall and Kevin McGuinness Appointed to Ellex Board
4. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
5. David Mott Appointed Non Executive Director at Shire
6. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
7. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
8. Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
9. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
10. Chris Tihansky Appointed President of In Vivo Cellular Imaging Leader Cellvizio Inc.
11. Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2017)... WARRINGTON, Pa. , Feb. 15, 2017 /PRNewswire/ ... ), a biotechnology company focused on developing aerosolized ... that it has completed a $10.5 million private ... expects that it has sufficient capital to fund ... 2b clinical trial data release in mid-2017. ...
(Date:2/15/2017)... , ... February 15, 2017 , ... ... will hold its sixth annual open house and technology show, Morris Madness, March ... live metal cutting demos from Okuma, Tsugami and Hardinge Group in addition to ...
(Date:2/15/2017)... 2017  Surrozen Inc., a newly formed biopharmaceutical company ... repair and regeneration of human tissues, has closed a ... Group, a science-driven venture capital firm based in ... used to implement a broad-based drug discovery platform aimed ... plays a central role in organism development, stem-cell maintenance ...
(Date:2/15/2017)... Group, a leading cosmetics company in China ... world, the company has successfully printed the skin of Asians ... to assure the smooth and reliable progress of the project, ... cell biology, pharmaceutical and regenerative medicine scientists from both ... After 98 experiments, the R&D team built the first Asian ...
Breaking Biology Technology:
(Date:1/24/2017)... Biopharm Reports has carried out a ... nuclear magnetic resonance spectroscopy (NMR). This involved the ... practices, developments, trends and end-user plans over the ... opportunities. These areas include growth in the use ... innovation requirements, hyphenated NMR techniques, main suppliers of ...
(Date:1/19/2017)... , January 19, 2017 According to a new ... and Forecast, 2014 - 2022," the global biometric sensor market is expected to ... to 2022. In 2015, Asia-Pacific dominated the global market ... private sectors. Continue Reading ... ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
Breaking Biology News(10 mins):